1. Executive Summary
2. Research Methodology
3. mHealth
3.1 Introduction
3.1.1 Overview
3.1.2 Business Models
3.1.3 Application Areas
3.2 Market Analysis
3.2.1 Market Sizing (Actual & Forecasted)
3.2.2 Market Share by End-Use
3.2.3 Market Share by Region
4. mHealth Apps
4.1 Introduction
4.1.1 Overview
4.1.2 Segmentation
4.1.3 mHealth Value Chain Analysis
5. Market Analysis
5.1 Market Sizing (Actual & Forecasted)
5.1.1 Market Sizing by Value (Actual & Forecasted)
5.1.2 Market Sizing by Volume (Actual & Forecasted)
5.2 Market Share Analysis
5.2.1 Market Share by Type
5.2.2 Market Share by Platform
5.2.3 Market Share by End-User
5.2.5 Market Share by Distribution Channel
5.2.6 Market Share by Region
6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.1.2.1 Market Size by Value (Actual & Forecasted)
6.1.2.2 Market Size by Volume (Actual & Forecasted)
6.1.2.3 Market Share by Distribution Channel
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Germany
6.2.2.1 Market Size by Value (Actual & Forecasted)
6.2.2.2 Market Size by Volume (Actual & Forecasted)
6.2.2.3 Market Share by App Type
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
6.3.2 Market Share by Nations
6.3.3 Japan
6.3.3.1 Market Size by Value (Actual & Forecasted)
6.3.3.2 Market Size by Volume (Actual & Forecasted)
6.3.4 China
6.3.4.1 Market Size by Value (Actual & Forecasted)
6.3.4.2 Market Size by Volume (Actual & Forecasted)
6.3.5 India
6.3.5.1 Market Size by Value (Actual & Forecasted)
6.3.5.2 Market Size by Volume (Actual & Forecasted)
7. Market Dynamics
7.1 Industrial Trends & Developments
7.1.1 Apps for Different Healthcare Segments
7.1.2 Mergers & Acquisitions
7.2 Growth Drivers
7.2.1 Higher Adoption of Smartphones
7.2.2 Growing Internet Penetration
7.2.3 Better Health Management
7.2.4 Cost Effective
7.3 Challenges
7.3.1 Behavioral Barriers
7.3.2 Reimbursement Issues
7.3.3 Lack of Standardization and Interoperability
7.3.4 Security Risks
8. Competitive Landscape
9. Company Profiles
9.1 Abbott Laboratories
9.2 Johnson & Johnson
9.3 Novartis International AG
9.4 AstraZeneca plc
9.5 Pfizer Inc.